The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Anticipated For The Pharmaceutical Safety Assessment Market Over The Period 2026–2030?
The pharmaceutical safety assessment market size has shown significant expansion in recent years. It is projected to increase from $11.32 billion in 2025 to $12.24 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.2%. This historical growth can be linked to the broadening of pharmaceutical R&D pipelines, heightened regulatory scrutiny on drug safety, an increase in preclinical and clinical testing volumes, the expanded adoption of in-vitro safety assessment methods, and the rising utilization of CRO-led safety studies.
The pharmaceutical safety assessment market is poised for robust expansion over the coming years. Its valuation is projected to reach $16.97 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.5%. This anticipated growth during the forecast period stems from factors such as a greater reliance on computational safety evaluation, the broadening scope of personalized medicine development, an escalating need for expedited regulatory clearances, the increasing incorporation of AI in drug safety processes, and elevated post-market surveillance mandates. Key trends defining this period encompass the expanded deployment of AI-powered toxicity prediction tools, an uptick in the embrace of in-silico safety evaluation models, the progressive integration of real-time pharmacovigilance frameworks, the proliferation of automated preclinical testing platforms, and a heightened emphasis on safety analytics that conform to regulatory standards.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=29147&type=smp
Which Economic Or Industry Drivers Are Impacting The Pharmaceutical Safety Assessment Market?
The expansion of clinical trials is projected to fuel the advancement of the pharmaceutical safety assessment market moving forward. Clinical trials are defined as human research studies conducted to evaluate the safety, effectiveness, and potential side effects of new medical treatments, drugs, or interventions. The rise in clinical trials is driven by the increasing need for new and effective treatments, as researchers and healthcare providers aim to develop therapies that can better prevent, manage, or cure diseases. Clinical trials bolster pharmaceutical safety assessment by systematically evaluating a drug’s effects on humans through carefully controlled studies, monitoring for adverse reactions, determining safe dosage ranges, and providing vital data that regulatory authorities use to ensure medications are both effective and safe for public consumption. For instance, in September 2025, according to the National Library of Medicine (NLM), a US-based biomedical library, a total of 554,798 studies were registered on ClinicalTrials.gov as of September 26, 2025. Therefore, the growth of clinical trials is a significant driver for the pharmaceutical safety assessment market.
How Is The Pharmaceutical Safety Assessment Market Divided Into Its Major Segments?
The pharmaceutical safety assessment market covered in this report is segmented –
1) By Type: In-Vitro Safety Assessment, In-Vivo Safety Assessment, Computational Safety Assessment
2) By Drug Type: Biological Drugs, Chemical Drugs
3) By Phase: Preclinical, Clinical (Phase I, II, III), Post-Market Surveillance (Phase IV)
4) By End User: Pharmaceutical Companies, Biotechnology Companies, Medical Device Companies, Academic And Research Institutions, Contract Research Organizations (CROs)
Subsegments:
1) By In-Vitro Safety Assessment: Cell-Based Assays, Organotypic Models, Tissue Culture Models, High-Throughput Screening
2) By In-Vivo Safety Assessment: Rodent Studies, Non-Rodent Studies, Toxicokinetic Studies, Carcinogenicity Studies
3) By Computational Safety Assessment: Quantitative Structure-Activity Relationship (QSAR) Modeling, Physiologically Based Pharmacokinetic (PBPK) Modeling, Toxicity Prediction Software, In Silico Simulation Studies
How Are Trends Transforming The Pharmaceutical Safety Assessment Market Landscape?
Leading companies in the pharmaceutical safety assessment market are concentrating on creating AI-driven decision support tools to boost the accuracy and efficiency of toxicity prediction and safety profiling. An AI-powered decision support tool functions as a software system that utilizes artificial intelligence to examine data and yield insights, thereby supporting faster and more precise decision-making. As an illustration, in April 2024, Charles River Laboratories, a US-based life sciences company, in collaboration with Deciphex, an Ireland-based company renowned for improving diagnostic precision and speed through AI-driven quality assurance, unveiled the Patholytix Foresight platform. This AI-powered decision support tool is specifically designed to transform toxicologic pathology within pharmaceutical safety assessment. The platform leverages artificial intelligence to rapidly analyze intricate preclinical pathology data, aiding in the earlier detection of potential safety risks and minimizing subjectivity in outcomes. Its distinct features comprise an AI algorithm capable of detecting tissue abnormalities, a cloud-based system for global collaboration, and a scalable architecture that reduces slide review duration while enhancing data accuracy and consistency.
Who Are The Prominent Organizations Shaping The Pharmaceutical Safety Assessment Market?
Major companies operating in the pharmaceutical safety assessment market are IQVIA Holding Inc., LabCorp (formerly Covance), Thermo Fisher Scientific (PPD), Charles River Laboratories, ICON plc, Parexel International Corp., Syneos Health, Eurofins Scientific SE, Wuxi Biologics Inc., SGS SA, Medpace Holdings Inc., Fujifilm Wako (Fujifilm Corp.), Pharmaron Beijing Co. Ltd., Inotiv (incl. Envigo), Evotec (Cyprotex), Intertek Group, Altasciences Inc., Aragen Life Sciences Ltd., CTI Clinical Trial and Consulting Inc., ChemDiv Inc., Frontage Laboratories, Medicilon Inc., Biotoxtech Co. Ltd., BioIVT, Accelera Srl.
Read the full pharmaceutical safety assessment market report here:
What Are The Top-Performing Regions Within The Pharmaceutical Safety Assessment Market?
North America was the largest region in the pharmaceutical safety assessment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical safety assessment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Pharmaceutical Safety Assessment Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=29147&type=smp
Browse Through More Reports Similar to the Global Pharmaceutical Safety Assessment Market 2026, By The Business Research Company
Pharmaceutical Chemicals Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmaceutical-chemicals-global-market-report
Pharmacovigilance Market Report 2026
https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report
Pharmaceuticals Market 2026
https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model